HTG Molecular Diagnostics (HTGM) Reports Q4 Loss of $0.76/Share

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q4 EPS of ($0.76), versus ($0.83) reported last year. Revenue for the quarter came in at $1.5 million, versus $1.22 million reported last year.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• DA Davidson Reiterates Neutral Rating on Brunswick Corp (BC)
• The LGL Group (LGL) Misses Q2 EPS by 8c